Physician profile

Michael Diaz

Medical Oncology · St Petersburg, FL

NPI 1871574186

$22,216.24

in general payments reported to CMS, 2019-2025

96 companies · $4,361 in 2025

The $4,361 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$12,920.96

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $3,167.10 2022-2025 Epkinly, Venclexta
Novartis Pharmaceuticals Corporation $1,434.09 2019-2025
Pfizer INC. $1,027.99 2019-2025
Daiichi Sankyo INC. $1,015.95 2022-2025 Enhertu, Datroway
Astrazeneca Pharmaceuticals Lp $943.30 2019-2025 Imfinzi, Enhertu, Calquence
Janssen Biotech, INC. $854.35 2019-2025 Talvey, Darzalex, Tecvayli
Lilly USA, LLC $799.31 2019-2025 Verzenio, Jaypirca, Retevmo
E.R. Squibb & Sons, L.L.C. $772.64 2019-2025 Opdivo, Krazati, Eliquis
Gilead Sciences, INC. $600.62 2019-2025 Trodelvy
Rigel Pharmaceuticals, INC. $537.86 2019-2025 Rezlidhia, Tavalisse, Tavalisse
Merck Sharp & Dohme LLC $534.41 2019-2024 Keytruda, Lynparza, Welireg
Genzyme Corporation $530.94 2019-2025
Takeda Pharmaceuticals U.S.A., INC. $507.37 2019-2025 Fruzaqla, Alunbrig, Ninlaro
Eisai INC. $454.52 2019-2025
Astellas Pharma US INC $435.04 2019-2025 Padcev, Xospata, Xtandi
Show all 96 companies
CompanyGeneral paymentsYearsTop products
Regeneron Healthcare Solutions, INC. $402.56 2022-2025 Libtayo
Genentech USA, INC. $357.05 2019-2024 Phesgo, Lunsumio, Perjeta
Incyte Corporation $339.15 2019-2025 Jakafi, Monjuvi, Zynyz
Glaxosmithkline, LLC. $309.51 2023-2025 Ojjaara, Jemperli, Zejula
Amgen INC. $302.59 2019-2023 Vectibix, Xgeva, Nplate
Emd Serono, INC. $271.39 2019-2025 Bavencio, Tepmetko
Seagen INC. $250.71 2019-2023 Tukysa, Adcetris, Padcev
Celgene Corporation $249.27 2019-2024 Reblozyl
Kyowa Kirin, INC. $238.66 2019-2024 Poteligeo
Johnson & Johnson Health Care Systems INC. $227.16 2022-2024 Darzalex, Stelara
Organon LLC $226.59 2022-2023 Ontruzant
Array Biopharma INC $213.00 2019-2025 Braftovi, Mektovi, Lorbrena
Pharmaessentia USA Corporation $196.76 2022-2025 Besremi
Merz North America, INC. $194.71 2019-2022
Cardinal Health 108 LLC $193.83 2019
Sobi, INC $189.85 2023-2025
Bayer Healthcare Pharmaceuticals INC. $186.03 2019-2025
Taiho Oncology, INC. $184.50 2022-2025
Novocure INC. $170.19 2019
Dendreon Pharmaceuticals LLC $159.82 2022-2025 Provenge
Exelixis INC. $155.95 2019-2025 Cabometyx
Tersera Therapeutics LLC $147.49 2019-2025 Zoladex, Quzyttir
Janssen Pharmaceuticals, INC $145.69 2022-2024 Xarelto
Adc Therapeutics America, INC. $145.32 2022-2025
Alexion Pharmaceuticals, INC. $144.17 2019-2025 Ultomiris
Blueprint Medicines Corporation $131.70 2022-2025 Ayvakit
Springworks Therapeutics, INC. $131.08 2024-2025 Ogsiveo
Kite Pharma, INC. $124.94 2020-2025 Yescarta
Foundation Medicine, INC. $111.89 2019-2023
Heron Therapeutics, INC. $105.54 2019
Puma Biotechnology, INC. $104.73 2019-2025
Pharmacyclics LLC, An Abbvie Company $103.60 2019-2023 Imbruvica
Legend Biotech USA INC. $101.68 2025 Carvykti
Stemline Therapeutics INC. $100.56 2024-2025 Orserdu
Aveo Pharmaceuticals, INC. $98.70 2022-2025
Intuitive Surgical, INC. $98.61 2022
Karyopharm Therapeutics INC. $98.20 2023-2025 Xpovio
Fennec Pharmaceuticals, INC. $97.14 2024-2025 Pedmark, Fyarro
Syndax Pharmaceuticals, INC. $95.32 2025
Adaptive Biotechnologies Corporation $91.96 2023-2025 Clonoseq
Pharmacosmos Therapeutics INC. $80.21 2023-2024 Monoferric, Cosela
Boehringer Ingelheim Pharmaceuticals, INC. $77.25 2023-2025 Gilotrif
Ipsen Biopharmaceuticals, INC $76.30 2022-2025 Somatuline Depot, Onivyde
Deciphera Pharmaceuticals INC. $71.25 2023-2025 Qinlock, Tgct
Sumitomo Pharma America, INC. $68.87 2023-2024 Orgovyx
Jazz Pharmaceuticals INC. $60.37 2024-2025
Novo Nordisk INC $59.28 2023-2024 Novoeight, Novoseven, Rebinyn
Global Blood Therapeutics, INC. $53.57 2022
Boston Scientific Corporation $51.95 2024
Myriad Genetic Laboratories, INC. $49.77 2022-2023 Myrisk
Servier Pharmaceuticals LLC $47.35 2025
Genmab U.S., INC. $47.08 2024 Epkinly
Apellis Pharmaceuticals, INC. $46.39 2022
Mirati Therapeutics, INC. $44.32 2023-2024 Krazati
Medtronic, INC. $44.14 2025 Kyphon Express II Kyphopak Tray
Cti Biopharma Corp. $40.62 2023 Vonjo
Myovant Sciences INC. $39.45 2022
Csl Behring $33.85 2024-2025 Hemgenix, Idelvion
Beone Medicines USA, INC. $30.25 2025 Brukinsa
Agios Pharmaceuticals, INC. $29.38 2019
Eusa Pharma (US) LLC $26.90 2019-2022
Beigene USA, INC. $24.46 2025 Brukinsa
Abiomed $23.26 2024 Impella
Genentech, INC. $22.96 2025 Itovebi
Napo Pharmaceuticals INC $22.50 2024 Gelclair Concentrated Oral Gel
Shockwave Medical, INC $20.43 2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Geron Corporation $20.02 2024 Rytelo
Amneal Pharmaceuticals LLC $19.61 2024 Avastin
Tg Therapeutics, INC. $18.70 2022
Ge Healthcare $17.33 2022
Sun Pharmaceutical Industries INC. $16.23 2025
Progenics Pharmaceuticals, INC. $15.68 2023 Pylarify
Alnylam Pharmaceuticals INC. $14.26 2023 Givlaari
Sirtex Medical INC $14.17 2019
Acrotech Biopharma INC. $14.04 2022
G1 Therapeutics, INC. $13.13 2023 Cosela
Epizyme, INC. $12.89 2022
Dova Pharmaceuticals $12.18 2019
Horizon Therapeutics Plc $11.36 2019
Aurobindo Pharma USA, INC. $10.83 2019
Veracyte, INC. $0.56 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael Diaz

$22,216.24

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $4,361 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).

https://glasscript.com/doctor/266882/michael-diaz

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.